Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors.

Blood
M RembergerO Ringdén

Abstract

The long-term follow-up of a study including 214 patients receiving either peripheral blood stem cells (PBSCs) or bone marrow (BM) from an HLA-A, -B, and -DR-compatible unrelated donor is presented. Median follow-up was 4.4 (2.3-7.3) and 5.0 (0.7-8.4) years in the 2 groups, respectively. Cumulative incidence of overall chronic graft-versus-host disease (GVHD) was similar in the 2 groups (78% vs 71%), while extensive chronic GVHD was significantly more common in the PBSC group compared with the BM group (39% vs 24%, P = .03). The 5-year transplant-related mortality (TRM) was 37% in the PBSC group and 35% in the BM controls (P = .7), and overall survival was 42% in both groups. The relapse incidences were 26% and 27% in the 2 groups, respectively, resulting in a disease-free survival of 41% in both groups. In conclusion, PBSCs from HLA-compatible unrelated donors results in similar outcome compared to BM but implies an increased risk for extensive chronic GVHD.

References

Aug 1, 1980·The American Journal of Medicine·H M ShulmanE D Thomas
Mar 4, 1993·The New England Journal of Medicine·N A KernanJ McCullough
Jul 20, 2002·Blood·Norbert SchmitzUNKNOWN European Group for Blood and Marrow Transplantation
Oct 18, 2002·Blood·Mohamad MohtyUNKNOWN Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O RingdénF Frassoni
Jan 14, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mats RembergerOlle Ringdén
Jun 28, 2003·Blood·Norbert C GorinUNKNOWN European Cooperative Group for Blood and Marrow Transplantation Acute Leukemia Working Party

❮ Previous
Next ❯

Citations

Feb 28, 2008·Current Opinion in Oncology·Ebru Koca, Richard E Champlin
Mar 1, 2012·Haematologica·Jose A Pérez-SimónHans Hagglund
Jan 7, 2006·Leukemia & Lymphoma·David I Marks
Jun 7, 2005·Expert Opinion on Biological Therapy·Jose C Jaime-PerezDavid Gomez-Almaguer
Dec 3, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sally AraiUNKNOWN Graft-vs-Host Disease Working Committee of the CIBMTR
Sep 9, 2009·British Journal of Haematology·Olle RingdénMichael Uhlin
Jan 26, 2013·Environment International·Lena WindlerBernd Nowack
Sep 28, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ann WoolfreyStephanie J Lee
Feb 17, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Olle Ringdén, Katarina Le Blanc
Jan 12, 2007·British Journal of Haematology·Jeffrey K Davies, Eva C Guinan
Mar 31, 2007·Mycoses·Andreas GlöcknerOliver A Cornely
Apr 24, 2012·Journal of Internal Medicine·O RingdénUNKNOWN Acute Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT)
Jun 22, 2010·British Journal of Haematology·Bronwen E ShawJ Alejandro Madrigal
Apr 29, 2015·Bone Marrow Transplantation·U DeotareJ H Lipton
Jan 21, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Byung-Sik ChoChong-Won Park
Nov 24, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hartmut BertzJürgen Finke
Oct 24, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Roland MeiselDagmar Dilloo
Nov 21, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mary EapenClaudio Anasetti
Nov 7, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·David S SnyderStephen J Forman
Jun 29, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Lidia De FeliceWilliam Arcese
Oct 8, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Kenneth R CookeBruce R Blazar
Sep 16, 2010·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Ying-Mei Liu, Marilyn Hockenberry
Dec 24, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary EapenRichard E Champlin
Mar 23, 2006·Blood·Corey CutlerEdwin Alyea
Feb 5, 2019·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nicole L ProkopishynBronwen E Shaw

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.